(b)(4).The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to failure to capture, high capture thresholds, infection/sepsis and erosion of the device pocket.
|
It was reported that this patient with this cardiac resynchronization therapy defibrillator (crt-d) exhibited an alert for left ventricular automatic threshold (lvat) detected greater than programmed amplitude or suspended.In addition, during the automatic lv threshold test, there are observations of loss of capture inappropriately marked as fusion beats.Technical service was consulted and offered troubleshooting suggestions.Subsequently, approximately one week after the reported lvat alert observations, the patient exhibited device erosion and infection which required surgical intervention.The crt-d system was explanted and replaced.No additional adverse patient effects were reported.
|